Population-Pharmacokinetic and Covariate Analysis of Lurbinectedin (PM01183), a New RNA Polymerase II Inhibitor, in Pooled Phase I/II Trials in Patients with Cancer
2018; Adis, Springer Healthcare; Volume: 58; Issue: 3 Linguagem: Inglês
10.1007/s40262-018-0701-2
ISSN1179-1926
AutoresCarlos Fernández‐Teruel, Ignacio Ferreira González, Iñaki F. Trocóniz, Rubin Lubomirov, A. Soto, Salvador Fudio,
Tópico(s)Lung Cancer Research Studies
Referência(s)